<DOC>
	<DOCNO>NCT01142297</DOCNO>
	<brief_summary>This study compare pattern dental implant stabilization standard chemically modify implant surface patient type 2 diabetes . It hypothesize chemically modify surface enhance early healing event ( first 4 month follow placement ) diabetes patient compromise rate implant integration .</brief_summary>
	<brief_title>Comparative Study Implant Surfaces Enhance Stabilization Patients With Type 2 Diabetes</brief_title>
	<detailed_description>This prospective randomized study design whereby type 2 diabetic patient receive 2 implant mandible maxilla ass implant integration . One implant regular SLA implant ; SLActive surface . The primary objective randomize control study evaluate stability Straumann 4.1 mm diameter implant posterior mandible maxilla type 2 diabetic patient first 12 week implantation use resonance frequency analysis . The control implant standard Straumann implant SLA® surface test implant implant design SLActive® surface . Assessments utilize resonance frequency analysis ( RFA ) , measure implant integration , clinical outcome implant success . This study enroll type 2 diabetes patient glycated hemoglobin ( HbA1c ) level 8.0 % 12 % baseline . The primary objective test statistically significant difference ISQ value test control implant 2 , 3 , 4 , 6 , 7 , 8 week 3 month surgery . If difference 2 Osstell RFA ISQ unit detect time point consider implant achieve high value well osseointegrated . This split-mouth study design ass change implant stability baseline primary outcome implant level . This study require 20 patient detect difference ( SD=2.0 ISQ unit ) power 80 % P=0.05 level . Secondary objective include : - Implant survival implant success 1-year post loading . - The nature frequency adverse events/complications 2 group compare . - Prosthesis success</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Males female must least 18 year age , diagnosis type 2 diabetes mellitus occur 1 year prior enrollment ( selfreported verify physician report , test result , and/or treatment record ) Type 2 diabetic patient may modify diet , oral medication , insulin , combination therapy Glycated hemoglobin A1c ( HbA1c ) level least 8.0 % include 12.0 % report within 4 week implant placement Have least two miss teeth posterior mandible FDI position 4 , 5 , 6 , 7 The tooth implant site must extract lose least 4 month date implantation Adequate bone quantity implant site permit insertion Straumann Standard Standard Plus 4.1 mm diameter implant least 8 mm length without use concurrent bone augmentation technique , i.e . Implant insertion site must sufficient bone height implant encroach vital structure sufficient width minimum 1 mm lingual buccal bone remain Patients must sign informed consent form . They must commit study . If treating clinician doubt patient willing able attend study followup visit patient admit study Patients history systemic disease type 2 diabetes mellitus may preclude dental implant therapy ( include cardiovascular , hepatic , renal , gastrointestinal , metabolic , neurologic , pulmonary , endocrine , autoimmune , psychiatric disorder ) Presence condition require chronic routine prophylactic use antibiotic ( e.g. , bacterial endocarditis , cardiac valvular anomaly , prosthetic joint replacement ) Diabetic retinopathy require imminent plan surgical intervention Diabetic neuropathy sufficient severity require treatment control symptoms Serum creatinine &gt; 1.6 mg/dl AST ( SGOT ) ALT ( AGPT ) &gt; 2 time upper limit normal laboratory range Hypertension , without medication , systolic pressure &gt; 185mm Hg diastolic pressure &gt; 105mm Hg Patient significant untreated oral infection inflammatory lesion Medical condition require prolong use steroid History leukocyte dysfunction deficiency History bleed disorder Patients history renal failure Patients metabolic bone disorder Physical handicap would interfere ability perform adequate oral hygiene Use investigational drug device within 30 day period immediately prior implant surgery study day 0 Patients smoke &gt; 10 cigarette per day cigar equivalent , chew tobacco Conditions circumstance , opinion investigator , would prevent completion study participation interfere analysis study result , history noncompliance , unreliability Local Factors : Signs oral inflammation , untreated periodontitis around teeth erosive lichen planus nontooth associate area History head/neck irradiation therapy Presence bone defect jaw prevent implant placement Unhealed extraction site ( less 4 month post extraction teeth intend site ) Bone surgery ( bone graft , guide tissue regeneration technique bone enhancement ) less 6 month prior implant placement Patients require bone graft surgical site time surgery Severe teeth grind clench habit Persistent intraoral infection Lack sufficient stability implant surgery allow proper healing . Patients inadequate oral hygiene unmotivated adequate home care</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>dental implant</keyword>
	<keyword>implant stabilization</keyword>
	<keyword>type 2 diabetes</keyword>
	<keyword>glycated hemoglobin 8.0-12.0 %</keyword>
</DOC>